US Stock MarketDetailed Quotes

FATE Fate Therapeutics

Watchlist
  • 1.330
  • -0.010-0.75%
Close Jan 24 16:00 ET
  • 1.330
  • 0.0000.00%
Post 20:01 ET
151.48MMarket Cap-0.81P/E (TTM)

Fate Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Dec 31, 2024

Based on 12 analysts giving stock ratings to Fate Therapeutics in the past 3 months

Buy

  • Buy

    25.00%
  • Hold

    75.00%
  • Sell

    0.00%

Price Target

Updated: Dec 31, 2024

The average Fate Therapeutics stock price target is 5.50 with a max estimate of 10.00 and a min estimate of 3.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 31, 2024

Buy

  • Buy

    25.00%
  • Hold

    75.00%
  • Sell

    0.00%

Price Target

Updated: Dec 31, 2024